Automated Molecular PCR Platform

NHS Blood and Transplant (NHSBT)contractContracts FinderRef CF-3393400D0O000000rwimUAAcomplete
View buyer

Estimated value

£404k

Awarded value

£338k

Awarded 18 Feb 2026

Suppliers

1

Lots

1

1 awarded

Published

18 Feb 2026

Deadline 03 Nov 2025

Description

In May 2023, universal, post-donation screening for HHV-8 antibodies was added to the portfolio of tests required for deceased organ donor characterisation in the UK. Routine pre-donation testing for other required infection markers continue to be performed on an urgent 24/7 basis by a network of UK wide NHS diagnostic laboratories. MSL Virology require a fully automated platform to perform testing for HHV8 DNA in plasma and whole blood samples. MSL Virology also requires a fully automated platform to perform testing for CMV DNA, HEV RNA and HBV DNA in EDTA plasma samples.

Scope

Reference
CF-3393400D0O000000rwimUAA
Total value
£404,382.6 excluding VAT
Commercial tool
Standalone contract
Contract dates
01 Dec 2025 to 30 Nov 2028
CPV classifications
38000000

Submission & procedure

Submission deadline
03 Nov 2025, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£338k

Award date

18 Feb 2026

Contract start

01 Dec 2025

Contract end

30 Nov 2028

Awarded to